Delivery Order SPE2DE23D0008-SPE2D625F3MUQ
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $1,495.00 fixed-price delivery order to Allergan USA Inc. on September 15, 2025, for Natrelle TE Smooth 133S-MX-12-T breast implants, with performance completion targeted for September 17, 2025. This delivery order, issued without set-aside designation, represents a child order under one of Allergan's two significant Indefinite Delivery Vehicles established with DLA Troop Support Medical in December 2022—specifically the $13.5 million...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $1,495.00 on September 2, 2025, for the supply of Natrelle TE Smooth 133S-MX-13-T breast implants. This fixed-price contract with economic price adjustment is funded by the Medical Supply Chain division of the Defense Logistics Agency Troop Support Medical and is scheduled for completion by September 4, 2025. The contract carries no set-aside designation, reflecting Allergan's status as a sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., received a $9,109 fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical on June 26, 2025, for Natrelle TE Smooth 133S-MV-11-T breast implants. This delivery order, which carries no set-aside designation, is scheduled for completion by June 30, 2025, with performance to be executed in Irvine, California. The award represents a child contract action under one of Allergan's two significant Indefinite Delivery...
- Allergan USA Inc., a subsidiary of AbbVie Inc., received a $2,990 fixed-price delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain on September 5, 2025, for Natrelle TE Smooth 133S-MX-14-T breast implants. This delivery order, with an ultimate completion date of September 9, 2025, represents a child award under one of Allergan's two significant Indefinite Delivery Vehicles (IDVs) established with DLA Troop Support Medical on December 8, 2022. The larger IDV supporting this...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $2,990.00 for Natrelle TE Smooth 133S-MV-14-T breast implants under a fixed-price contract with economic price adjustment. The award was issued on September 11, 2025, with an ultimate completion date of September 25, 2025, and carries no set-aside designation, reflecting Allergan's status as a sole-source provider of these specialized medical devices. The product will be delivered to Irvine, California,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $2,990 fixed-price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for Natrelle TE Smooth 133S breast implants. The contract, awarded on August 19, 2025, with an ultimate completion date of August 21, 2025, represents a child order under one of Allergan's two significant Indefinite Delivery Vehicles established with DLA Troop Support Medical. This $13.5 million IDV, awarded on December 8, 2022, supports...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,990 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on July 10, 2025, for Natrelle TE Smooth 133S breast implants. This delivery order, which carries an ultimate completion date of July 28, 2025, represents a child award under one of Allergan's two significant Indefinite Delivery Vehicle contracts established with DLA Troop Support Medical on December 8, 2022. The award was made without...
- Allergan USA Inc., a subsidiary of Abbvie Inc., has been awarded a $1,495 fixed-price delivery order by the Defense Logistics Agency Troop Support Medical to provide 4563183739 NATRELLE TE Smooth 133S-MX-12-T breast implants. The order was awarded on December 14, 2023 under the company's $13.5 million Indefinite Delivery Indefinite Quantity contract, which supplies breast implants, surgical instruments, and specialty components to support reconstructive surgeries at Military Treatment...
- This is a $1,495.00 delivery order awarded by the Defense Logistics Agency Troop Support Medical to Allergan USA Inc., a subsidiary of AbbVie Inc. The contract is for the delivery of NATRELLE TE SMOOTH 133S-MX-14-T breast implants, a specialized medical device used in reconstructive and aesthetic surgical procedures. The contract is a fixed-price award with economic price adjustment, with a period of performance extending to April 2025. This delivery order is part of a larger $4.9 million...
- The Defense Logistics Agency Troop Support Medical awarded a $2,990.00 fixed-price delivery order to Allergan USA Inc., a subsidiary of AbbVie Inc., for the procurement of Natrelle TE Smooth 133S-FX-15-T breast implants. This contract has a period of performance through March 8, 2024 and does not utilize a set-aside designation. Allergan is a major supplier of reconstructive and aesthetic medical devices, including breast implants, tissue expanders, and surgical instruments, to federal...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D625F3MUQDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $1,495.00 fixed-price delivery order to Allergan USA Inc. on September 15, 2025, for Natrelle TE Smooth 133S-MV-14-T breast implants. This delivery order, which represents a child contract under one of Allergan's larger Indefinite Delivery Vehicles, is scheduled for completion by September 17, 2025, with the place of performance in Irvine, California. The contract includes economic price adjustment provisions and was awarded without set-aside designation, reflecting Allergan's position as a sole-source provider of these specialized medical devices to the federal government. Allergan USA Inc., a subsidiary of AbbVie Inc., serves as a critical supplier of breast implants and surgical reconstruction products to the Department of Defense through the Defense Logistics Agency. The company maintains two significant IDVs totaling $18.4 million established in December 2022, which support reconstructive and aesthetic surgical procedures across military treatment facilities, Veterans Affairs hospitals, and Indian Health Service centers. This delivery order fulfills ongoing demand for Natrelle-branded implants that support surgical procedures for military members, veterans, and Native American populations served by the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/15/25 |